Filing Flows

Filing Flows › GeoVax Labs (GOVX) › Who owns the stock

Who owns GeoVax Labs (GOVX) stock

17 funds reported GeoVax Labs (GOVX) shares in their latest 13F filings, worth $479K in all. The largest holder is Jane Street Group, LLC ($400K). Last quarter 6 funds added to their stakes and 7 cut them.

Largest holders of GOVX (13F)Largest holders of GOVX (13F)Jane Street Group, LLC$400KGeode Capital Management, LLC$27KStoneX Group$14KTwo Sigma Securities, LLC$14KVanguard Fiduciary Trust$6KTower Research Capital LLC$4KVanguard Capital Management LLC$4KSBI Securities$3KMorgan Stanley$3KJones Financial Companies Lllp$1K

Largest holders (13F)

FundSharesValueChangeQuarter
Jane Street Group, LLC315,275$400Knew2026-06-30
Geode Capital Management, LLC21,112$27Kdecrease2026-06-30
StoneX Group21,145$14Knew2026-09-30
Two Sigma Securities, LLC10,682$14Knew2026-06-30
Vanguard Fiduciary Trust5,068$6Kunchanged2026-06-30
Tower Research Capital LLC3,502$4Kdecrease2026-06-30
Vanguard Capital Management LLC3,217$4Kunchanged2026-06-30
SBI Securities2,588$3Kincrease2026-06-30
Morgan Stanley2,003$3Kincrease2026-06-30
Jones Financial Companies Lllp1,000$1Knew2026-06-30
UBS Group AG944$1Kdecrease2026-06-30
BlackRock842$1Kdecrease2026-06-30
Citigroup230$292new2026-06-30
Wells Fargo30$38decrease2026-06-30
Danske Bank A/S3$4unchanged2026-06-30

GeoVax Labs' latest quarter

GeoVax Labs, Q2 2025: revenue $852K (+184% year over year), operating margin -635.8%, net loss $5.4M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most GOVX stock?

By the latest 13F filings: Jane Street Group, LLC ($400K); Geode Capital Management, LLC ($27K); StoneX Group ($14K); Two Sigma Securities, LLC ($14K); Vanguard Fiduciary Trust ($6K).

What is the short interest in GOVX?

270,211 shares were sold short at the 2026-10-15 settlement, -4.1% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.